1. Bishop J.E. Soaring medical costs and the Mayo “epidemic”. The Wall Street Journal 1980, 26.
2. Rao D.S. Primary hyperparathyroidism: changing patterns in presentation and treatment decisions in the Eighties. Henry Ford Hospital Med. J. 1985, 33: 194–197.
3. Rao D.S., Phillips E., Honasoge M., Mithal A., Mishra S.D., Singh A.K., Han Z.-H., Parikh N., Lee M., Talpos G.B. Role of vitamin D nutrition in primary hyperpa-rathyroidism: effect on parathyroid gland mass and on bone. In: Norman A.W., Boullion R., Thomasset M. (Eds.), Vitamin D: Chemistry, biology, and clinical applications of the steroid hormone. University of California-Riverside, Riverside, 1997, pp. 723–724.
4. Rao D.S., Honasoge M., Divine G.W., Phillips E.R., Lee M.W., Ansari M.R., Talpos G.B., Parfitt A.M. Effect of vitamin D nutrition on parathyroid ade noma weight: pathogenetic and clinical implica tions. J. Clin. Endocrinol. Metab. 2000, 85: 1054–1058.
5. Rastad J. Parathyroidectomy for asymptomatic primary hyper-parathyroidism (PHPT): Is it worth the risk? J. Endocrinol. Invest. 2001, 23: 56–61.